76 related articles for article (PubMed ID: 22915026)
1. Therapy for metastatic melanoma: the past, present, and future.
Finn L; Markovic SN; Joseph RW
BMC Med; 2012 Mar; 10():23. PubMed ID: 22385436
[TBL] [Abstract][Full Text] [Related]
2. Targeting invasive properties of melanoma cells.
Arozarena I; Wellbrock C
FEBS J; 2017 Jul; 284(14):2148-2162. PubMed ID: 28196297
[TBL] [Abstract][Full Text] [Related]
3. Alternative Treatments For Melanoma: Targeting BCL-2 Family Members to De-Bulk and Kill Cancer Stem Cells.
Mukherjee N; Schwan JV; Fujita M; Norris DA; Shellman YG
J Invest Dermatol; 2015 Sep; 135(9):2155-2161. PubMed ID: 25947358
[TBL] [Abstract][Full Text] [Related]
4. Emerging targeted therapies for melanoma treatment (review).
Russo A; Ficili B; Candido S; Pezzino FM; Guarneri C; Biondi A; Travali S; McCubrey JA; Spandidos DA; Libra M
Int J Oncol; 2014 Aug; 45(2):516-24. PubMed ID: 24899250
[TBL] [Abstract][Full Text] [Related]
5. COX-2 as a potential biomarker and therapeutic target in melanoma.
Tudor DV; Bâldea I; Lupu M; Kacso T; Kutasi E; Hopârtean A; Stretea R; Gabriela Filip A
Cancer Biol Med; 2020 Feb; 17(1):20-31. PubMed ID: 32296574
[TBL] [Abstract][Full Text] [Related]
6. Fast-growing in-transit melanoma metastasis after intratumoral interleukin-2.
Moreno-Ramírez D; Alés-Martínez M; Ferrándiz L
Cancer Immunol Immunother; 2014 Nov; 63(11):1229-30. PubMed ID: 25056817
[No Abstract] [Full Text] [Related]
7. Limited efficacy of intratumoral IL-2 applied to large melanoma metastases.
Weide B; Eigentler TK; Elia G; Neri D; Garbe C
Cancer Immunol Immunother; 2014 Nov; 63(11):1231-2. PubMed ID: 25056818
[No Abstract] [Full Text] [Related]
8. Ferroptosis: a new unexpected chance to treat metastatic melanoma?
Gagliardi M; Saverio V; Monzani R; Ferrari E; Piacentini M; Corazzari M
Cell Cycle; 2020 Oct; 19(19):2411-2425. PubMed ID: 32816618
[TBL] [Abstract][Full Text] [Related]
9. Beta-adrenergic signaling, a novel target for cancer therapy?
Schuller HM
Oncotarget; 2010 Nov; 1(7):466-469. PubMed ID: 21317444
[No Abstract] [Full Text] [Related]
10. [Ⅱ. Update on Systemic Therapies for Melanoma and Non-Melanoma Skin Cancers].
Namikawa K
Gan To Kagaku Ryoho; 2024 Apr; 51(4):398-403. PubMed ID: 38644305
[No Abstract] [Full Text] [Related]
11. [Ⅳ. Future Directions for Systemic Pharmacotherapy of Skin Cancer].
Funakoshi T
Gan To Kagaku Ryoho; 2024 Apr; 51(4):409-411. PubMed ID: 38644307
[No Abstract] [Full Text] [Related]
12. Activation of the Kinin B1 Receptor by Its Agonist Reduces Melanoma Metastasis by Playing a Dual Effect on Tumor Cells and Host Immune Response.
Maria AG; Dillemburg-Pilla P; Durand MT; Floriano EM; Manfiolli AO; Ramos SG; Pesquero JB; Nahmias C; Costa-Neto CM
Front Pharmacol; 2019; 10():1106. PubMed ID: 31607931
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral delivery of mTORC2-deficient dendritic cells inhibits B16 melanoma growth by promoting CD8(+) effector T cell responses.
Raïch-Regué D; Fabian KP; Watson AR; Fecek RJ; Storkus WJ; Thomson AW
Oncoimmunology; 2016 Jun; 5(6):e1146841. PubMed ID: 27471613
[TBL] [Abstract][Full Text] [Related]
14. Is there a role for targeting vascular endothelial growth factor/receptor axis in the treatment of patients with metastatic melanoma?
Kim KB
Cancer; 2013 Feb; 119(3):477-80. PubMed ID: 22915026
[No Abstract] [Full Text] [Related]
15. Reactive oxygen species may have antitumor activity in metastatic melanoma.
Tuma RS
J Natl Cancer Inst; 2008 Jan; 100(1):11-2. PubMed ID: 18159075
[No Abstract] [Full Text] [Related]
16. A phase 2 clinical trial of nab-paclitaxel in previously treated and chemotherapy-naive patients with metastatic melanoma.
Hersh EM; O'Day SJ; Ribas A; Samlowski WE; Gordon MS; Shechter DE; Clawson AA; Gonzalez R
Cancer; 2010 Jan; 116(1):155-63. PubMed ID: 19877111
[TBL] [Abstract][Full Text] [Related]
17. Nivolumab success in untreated metastatic melanoma.
Wilkinson E
Lancet Oncol; 2015 Jan; 16(1):e9. PubMed ID: 25638562
[No Abstract] [Full Text] [Related]
18. Nab-paclitaxel in patients with metastatic melanoma.
Leon-Ferre RA; Markovic SN
Expert Rev Anticancer Ther; 2015; 15(12):1371-7. PubMed ID: 26536477
[TBL] [Abstract][Full Text] [Related]
19. [To outwit melanoma with its own tricks].
Bischoff A
MMW Fortschr Med; 2003 Apr; 145(15):4-6, 8, 10. PubMed ID: 15104255
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
